Kenya Minute.
Sunday, 4 October 2026
Kenya’s news, on the hour · Est. 2026
Sunday, 4 October 2026
Nairobi—:—London—:—New York—:—Beijing—:—
Kenyan press · Organization

Moderna

2026-06-012026-10-04

In coverage

Verbatim sentences from the source article.

  1. September 2026
  2. Citizen Digital

    … The donation supported research that later became connected to the development of Moderna's COVID-19 vaccine. …

    Nashville airport to be renamed after Dolly Parton
  3. August 2026
  4. Citizen Digital

    … Her Instagram page, with 8.6 million followers, became an online phenomenon, and at age 75 she unveiled a new fragrance, "Dolly." In 2020, the ally to the marginalized gave $1 million to Vanderbilt University, which helped develop Moderna's Covid-19 vaccine. …

    Dolly Parton: Country music's dolled up but deserving queen
  5. Citizen Digital

    … In response to the COVID-19 pandemic, Parton donated $1 million to vaccine research ​at Vanderbilt University in 2020, making her an early sponsor of Moderna's vaccine development. …

    Dolly Parton, queen of country music, dies at 80
  6. The Standard

    … Her Instagram page, with 8.6 million followers, became an online phenomenon, and at age 75 she unveiled a new fragrance, "Dolly." In 2020, the ally to the marginalized gave $1 million to Vanderbilt University, which helped develop Moderna's Covid-19 vaccine. …

    Dolly Parton: Country music's dolled up but deserving queen
  7. Citizen Digital

    Merck, Moderna claim 'promising' skin cancer vaccine results in key trial By AFP August 19, 2026 05:41 (EAT) Add as a Preferred Source on Google Follow us Follow on Whatsapp Follow on Google Follow on Twitter Audio By Vocalize US pharmaceutical firms Merck and Moderna announced W …

    Merck, Moderna claim 'promising' skin cancer vaccine results in key trial
  8. The Standard

    Audio By VocalizeVaccine manufacturer Moderna said Wednesday the US Food and Drug Administration (FDA) had approved its new influenza vaccine, nearly six months after the regulator briefly rejected an application for review. …

    US regulators approve Moderna flu vaccine
  9. Citizen Digital

    … On Tuesday, Canada gave the go-ahead to US pharmaceutical giant Moderna to begin clinical trials of a vaccine against the Bundibugyo strain of Ebola. …

    WHO chief in DR Congo for talks on Ebola reponse
  10. The Standard

    … On Tuesday, Canada gave the go-ahead to US pharmaceutical giant Moderna to begin clinical trials of a vaccine against the Bundibugyo strain of Ebola.The vaccine, said by the WHO as "the most promising" -- the rVSV Bundibugyo -- will also be developed by Singapore-based Hilleman L …

    WHO chief in DR Congo for talks on Ebola reponse
  11. Citizen Digital

    … The two front-running candidate vaccines are one using the ChAdOx1 platform, being developed by the University of Oxford and the Serum Institute of India, and another being worked on by US pharma firm Moderna using mRNA technology. …

    WHO pleads for more support to tackle Ebola outbreak
  12. June 2026
  13. Capital News

    … Leading candidates include vaccine programs developed by the University of Oxford in partnership with the Serum Institute of India, as well as mRNA-based vaccines from Moderna. …

    US Sends Experimental Ebola Drug to Support Clinical Trials in DR Congo

Friday 11 September

  1. Nashville airport to be renamed after Dolly Parton

    The Metropolitan Nashville Airport Authority voted unanimously to rename Nashville International Airport in honor of country music legend Dolly Parton, who died in August at age 80. A final name incorporating Parton's legacy is being determined.

    11 September 2026 · Citizen Digital →

Wednesday 26 August

  1. Dolly Parton, country music icon, dies at age 80

    US singer-songwriter Dolly Parton, who died Tuesday at age 80, was a prolific talent who wrote thousands of songs over six decades, including "Jolene" and "I Will Always Love You," which became an international hit for Whitney Houston.

    26 August 2026 · Citizen Digital →

Tuesday 25 August

  1. Country music icon Dolly Parton dies at eighty

    American country music star Dolly Parton, who won 11 Grammy awards and sold over 100 million records with classics including "Coat of Many Colors" and "Jolene," died on Tuesday aged 80, her family said.

    25 August 2026 · Citizen Digital →

  2. Country music legend Dolly Parton dies at eighty

    Dolly Parton, American singer-songwriter, actress, businesswoman and philanthropist who defined country music over six decades, has died at age 80. She penned 3,000 tunes including "Jolene" and "I Will Always Love You," released 49 studio albums, sold more than 100 million records, and topped the country charts more than any woman in the genre.

    25 August 2026 · The Standard →

Wednesday 19 August

  1. Merck and Moderna report positive melanoma vaccine trial results

    US pharmaceutical firms Merck and Moderna announced encouraging results from a trial of their experimental vaccine against melanoma, called intismeran autogene, which showed "statistically significant and clinically meaningful improvements" for skin cancer patients when used with Merck's Keytruda treatment.

    19 August 2026 · Citizen Digital →

Thursday 6 August

  1. US FDA approves Moderna's mRNA flu vaccine for adults fifty and older

    Moderna announced the US Food and Drug Administration approved its mFLUVISA flu vaccine for adults age 50 and older, with the company expecting availability for the 2026-2027 respiratory virus season. The FDA had initially rejected the application in February before reversing its decision a week later.

    6 August 2026 · The Standard →

  2. WHO chief visits DR Congo amid intensifying Ebola epidemic

    The World Health Organization's Director-General arrived in the Democratic Republic of Congo for talks with President Felix Tshisekedi as the country's 17th Ebola outbreak spreads at an "exceptional" pace. The outbreak, declared on May 15, has recorded 3,874 confirmed cases and 1,751 deaths.

    6 August 2026 · Citizen Digital →

Wednesday 5 August

  1. WHO chief visits DR Congo amid intensifying Ebola outbreak

    The WHO director general has arrived in the Democratic Republic of Congo for meetings with President Felix Tshisekedi as the Ebola epidemic spreads at an "exceptional" pace. The country's 17th Ebola outbreak, declared in May, has recorded 3,874 confirmed cases and 1,751 deaths, with the Bundibugyo virus variant currently lacking a vaccine or treatment.

    5 August 2026 · The Standard →

  2. WHO seeks increased support for DRC Ebola outbreak response

    The World Health Organization called for more financial and other resources to combat the Ebola outbreak in the Democratic Republic of Congo, which it described as the biggest ever to have hit the DRC and is still expanding beyond the capacity of response efforts. There have been 3,802 confirmed cases with 1,707 deaths, according to WHO figures.

    5 August 2026 · Citizen Digital →

Wednesday 24 June

  1. US sends experimental Ebola drug for DRC clinical trials

    The United States has provided doses of an experimental antibody drug developed by Mapp Biopharmaceutical to support clinical trials in the Democratic Republic of Congo's Ebola outbreak, marking a shift from prior US-only availability. The move comes as health authorities work to contain a rapidly spreading Bundibugyo strain outbreak that has recorded more than 1,000 cases and over 250 deaths.

    24 June 2026 · Capital News →

  2. US provides experimental Ebola drug for Congo outbreak trials

    The U.S. has provided doses of an experimental antibody drug from Mapp Biopharmaceutical for clinical trials in the Democratic Republic of Congo's Bundibugyo Ebola outbreak, which has caused over 1,000 cases and more than 250 deaths. The trial data could inform future U.S. regulatory review and potential approval.

    24 June 2026 · Citizen Digital →

  3. US provides experimental Ebola drug for Congo outbreak trials

    The U.S. has provided doses of an experimental antibody drug from Mapp Biopharmaceutical for use in clinical trials and compassionate use to fight an Ebola outbreak in Democratic Republic of Congo. The Bundibugyo strain has caused more than 1,000 cases in Congo and more than 250 deaths, with a handful of cases also reported in Uganda.

    24 June 2026 · Citizen Digital →

Thursday 18 June

  1. Vaccines and treatments urgently developed for Bundibugyo Ebola strain

    More than 875 cases of the Bundibugyo Ebola strain have been confirmed, including 202 deaths, in a little over a month across DR Congo and Uganda, with no currently available vaccines or treatments for this strain. Scientists and pharmaceutical companies are racing to develop new vaccines and treatments, with the WHO calling an rVSV-based vaccine candidate "most promising" and estimating it will take seven to nine months before human testing can begin.

    18 June 2026 · The Standard →

Monday 1 June

  1. Non-profits race to develop vaccine for rare Ebola strain in DRC

    Non-profit organisations announced Monday they are ramping up efforts to develop a vaccine for the Bundibugyo strain of Ebola, which has caused an outbreak in the Democratic Republic of Congo and Uganda with nearly 250 suspected deaths and more than 1,100 infections. The strain, for which there are no approved vaccines or treatments, has prompted a race to rapidly develop, manufacture and test a vaccine in clinical trials in the affected region.

    1 June 2026 · Citizen Digital →

Moderna — Kenyan press coverage · Kenya Minute